ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ: ZYBT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.92
+5.75% today
Updated 2026-04-30
Market cap
$43.72M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $14
Volume
0.3M
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-12.60%
Operating margin
-46.30%
ROE
-6.38%
ROA
-3.45%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $214.07M | $38.96M | 58.58% | 24.47% | 18.20% |
| 2022 | $260.27M | $46.73M | 58.98% | 25.29% | 17.96% |
| 2023 | $211.65M | $31.46M | 61.35% | 21.25% | 14.86% |
| 2024 | $186.36M | $11.31M | 48.99% | 9.21% | 6.07% |
| 2025 | $186.36M | $11.31M | 48.99% | 8.82% | 6.07% |